<DOC>
	<DOCNO>NCT01581203</DOCNO>
	<brief_summary>The purpose study estimate efficacy , determine proportion subject Sustained virologic response post-treatment Week 12 ( SVR12 ) , define Hepatitis C virus ( HCV ) Ribonucleic acid ( RNA ) &lt; Limit quantitation ( LOQ ) post-treatment Week 12 , subject prior null partial responder P/R treatment-naive .</brief_summary>
	<brief_title>Phase III Hallmark DUAL : ASV+DCV ( Nulls/Partials , Intolerants/Ineligibles . Naives )</brief_title>
	<detailed_description>Allocation : Treatment naive cohort : Randomized Controlled Trial , Null/partial responder intolerant/ineligible cohort : N/A ( Single arm study ) Masking : Treatment naive cohort : Double Blind , Null/partial responder intolerant/ineligible cohort : Open Intervention Model : Treatment naive cohort : Parallel , Null/partial responder intolerant/ineligible cohort : Single group</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<mesh_term>Peginterferon alfa-2a</mesh_term>
	<criteria>For information regard BMS clinical trial participation , please visit www.BMSStudyConnect.com Males female , ≥ 18 year age HCV Genotype 1b previously fail treatment peginterferon alfa ribavirin , classify previous null partial responder base previous therapy , OR intolerant ineligible P/R due neutropenia , anemia , depression thrombocytopenia fibrosis/cirrhosis , OR treatment naive HCV RNA ≥ 10,000 IU/mL Seronegative Human immunodeficiency virus ( HIV ) Hepatitis B surface antigen ( HBsAg ) Subjects compensated cirrhosis permit ( compensated cirrhotics cap approximately 25 % treated population ) Prior treatment HCV HCV direct act antiviral ( DAA ) Evidence medical condition contribute chronic liver disease HCV Evidence decompensated liver disease include , limited , history presence ascites , bleed varix , hepatic encephalopathy Diagnosed suspected hepatocellular carcinoma malignancy Uncontrolled diabetes hypertension</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>